In the News
In the Clinic
View By Issue
2017 Lynn Sage Breast Cancer Symposium
ESMO Asia 2017 Congress
2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
2017 Palliative Care in Oncology Symposium
9th World Congress of Melanoma
No results found for "Matthew Stenger"
Ensure words are spelled correctly.
Try rephrasing keywords or using synonyms.
Try less specific keywords.
Today In Oncology
ACKC Secures $10 Million for Kidney Cancer Research
Long-Term Risk of Breast Cancer Recurrence After 5 Years of Endocrine Therapy
Constructing a Risk Stratification Model for Pediatric Acute Lymphoblastic Leukemia
Seattle Children’s Opens Trial for Children and Young Adults With Leukemia That Targets CD22 and CD19 Proteins Simultaneously
ESMO Asia 2017: FLAURA Trial: Osimertinib Improves Progression-Free Survival in Asian Patients With
ESMO Asia 2017: AXEPT Trial: New Second-Line Therapy for Metastatic Colorectal Cancer Is Effective and Safe
Patient-Reported Outcomes With Immunotherapy vs Chemotherapy in Advanced NSCLC
Antidepressant for Aromatase Inhibitor–Associated Arthralgia in Early-Stage Breast Cancer
Most Read Stories
FDA Expands Approval of Sunitinib Malate for Adjuvant Treatment of Renal Cell Carcinoma After Nephrectomy
Novel Psychosocial Intervention for Fear of Cancer Recurrence
Cabozantinib Salvage Therapy in Tyrosine Kinase Inhibitor–Refractory Differentiated Thyroid Cancer
FDA Approves Fulvestrant in Combination With Abemaciclib in Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
Chronic Stress Hormones May Promote Resistance to EGFR Inhibitors in Patients With Lung Cancer
FDA Authorizes MSK-IMPACT Tumor Profiling Assay
Novel Tyrosine Kinase Inhibitor for
5-Year Outcomes With Extended Adjuvant Therapy in HER2-Positive Breast Cancer
ASCO 2017: I-SPY 2 Trial: Combination of Pembrolizumab Plus Standard Neoadjuvant Therapy in High-Risk Breast Cancer
© 2017 HSP News Service, L.L.C.